Question

A 58-year-old man with new NSTEMI undergoes PCI with a drug-eluting stent. No high bleeding risk. Which lipid therapy is indicated starting now?

Accepted Answer

High-intensity statin

Answer

Moderate-intensity statin with ezetimibe

Answer

PCSK9 inhibitor monotherapy

Answer

No statin until LDL results return

Answer

Bile acid sequestrant first-line

Practice question

A 58-year-old man with new NSTEMI undergoes PCI with a drug-eluting stent. No high bleeding risk. Which lipid therapy is indicated starting now?